NCT07101809

Brief Summary

The goal of this clinical trial is to compare Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System and standard ureteroscopy (URS) with laser lithotripsy for the treatment of urolithiasis. This is a prospective, randomized (1:1), multi-center study.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
41mo left

Started Sep 2025

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Sep 2025Sep 2029

First Submitted

Initial submission to the registry

July 25, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
29 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2029

Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

3 years

First QC Date

July 25, 2025

Last Update Submit

September 12, 2025

Conditions

Keywords

ureteroscopyCVACSURE

Outcome Measures

Primary Outcomes (1)

  • Residual Stone Volume (RSV)

    30-Day

Study Arms (2)

Standard Ureteroscopy (URS)

ACTIVE COMPARATOR

This is a treatment in which the urologist uses a laser to break a kidney stone into very small pieces and then places a tool called a stent to allows the remaining pieces to fall out.

Device: Standard Ureteroscopy (URS)

Steerable Ureteroscopic Renal Evacuation (SURE) with CVAC System

ACTIVE COMPARATOR

The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).

Device: Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System

Interventions

The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).

Also known as: CVAC
Steerable Ureteroscopic Renal Evacuation (SURE) with CVAC System

Arm Description: This is a treatment in which the urologist uses a laser to break a kidney stone into very small pieces and then places a tool called a stent to allows the remaining pieces to fall out.

Standard Ureteroscopy (URS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Candidate for ureteroscopy with laser lithotripsy
  • Be willing and able to return for and respond to all study-related follow up procedures
  • Have been informed of the nature of the study and has provided informed consent using the IRB approved informed consent (ICF)

You may not qualify if:

  • Untreated urinary tract infection at the time of the index procedure
  • Significant comorbidities
  • Bladder, ureteral or kidney abnormalities
  • Pregnant individuals
  • Unable to meet the treatment and follow up protocol requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

UrolithiasisKidney CalculiNephrolithiasis

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesKidney DiseasesUrinary CalculiCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2025

First Posted

August 3, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2029

Last Updated

September 18, 2025

Record last verified: 2025-09